解郁丸对注意缺陷多动共患焦虑障碍模型大鼠AKT/GSK-3β/β-catenin通路的影响OA
Effects of Jieyu Pills on AKT/GSK-3β/β-catenin Signaling Pathway in a Rat Model of Attention Deficit Hyperactivity Disorder with Comorbid Anxiety Disorder
目的:探讨解郁丸对注意缺陷多动共患焦虑障碍模型大鼠的保护作用及机制的研究.方法:采用慢性束缚应激法构建 SHR 大鼠注意力缺陷多动共患焦虑障碍模型,将 36 只 SHR 大鼠随机分为模型对照组、盐酸哌甲酯5.4 mg/kg 组、静灵口服液5.98 mL/kg 组、解郁丸0.7、1.3、2.7 g/kg 组,6 只 WKY 大鼠为正常对照组,每日灌胃给药,连续 14 d.末次给药后,采用 Morris 水迷宫、旷场、高架十字迷宫评估大鼠行为能力;ELISA 法检测大鼠前额叶皮质、纹状体、血清中 DA、5-HT 的含量;Western blot 和 Real-time PCR 法检测大鼠前额叶皮质、纹状体 AKT/GSK-3β/β-catenin 信号通路相关蛋白及 mRNA 表达.结果:与正常对照组相比,模型对照组大鼠 Morris水迷宫中有效穿梭次数明显升高(P<0.05),潜伏期显著缩短(P<0.01),旷场中运动时间和运动距离显著增加(P<0.01),前额叶、纹状体、血清中 DA、5-HT 含量显著降低(P<0.01),前额叶皮质、纹状体中 p-AKT/AKT、p-GSK-3β/GSK-3β、β-catenin/β-actin 蛋白表达下调(P<0.05 或 P<0.01),Akt、Bcatenin mRNA 表达明显下调(P<0.05 或 P<0.01),Gsk3b mRNA 表达上调(P<0.05 或 P<0.01);与模型对照组比,解郁丸 2.7 g/kg 组 Morris 水迷宫有效穿梭次数显著升高(P<0.01),潜伏期明显缩短(P<0.05),旷场试验的运动时间和运动距离显著缩短(P<0.01),高架十字迷宫试验闭臂滞留时间、闭臂进入次数百分率明显减少(P<0.05 或 P<0.01),前额叶皮质、纹状体、血清中DA、5-HT 的含量升高(P<0.05 或P<0.01),前额叶皮质、纹状体中p-AKT/AKT、p-GSK-3β/GSK-3β、β-catenin/β-actin 的蛋白表达上调(P<0.05 或 P<0.01),Akt、Bcatenin mRNA 表达上调(P<0.05 或 P<0.01),Gsk3b mRNA 表达显著下调(P<0.01).结论:解郁丸通过调控注意缺陷多动共患焦虑障碍模型大鼠前额叶皮质和纹状体 AKT/GSK-3β/β-catenin 信号通路的表达,上调此信号通路上相关蛋白和 mRNA 表达,下调 GSK-3β 的表达,减少 β-catenin 的降解,避免内质网应激,改善注意缺陷多动共患焦虑障碍模型大鼠的认知能力.
Objective:To investigate the protective effects and mechanisms of Jieyu Pills(解郁丸)on a rat model of attention deficit hyperactivity disorder(ADHD)comorbid with anxiety disorder.Methods:A rat model of ADHD comorbid with anxiety disorder was established in spontaneously hypertensive rats(SHRs)using chronic restraint stress.Thirty-six SHRs were randomly divided into a model control group,a methylphenidate hydrochloride group(5.4 mg/kg),a Jingling Oral Liquid group(5.98 mL/kg),and Jieyu Pills 0.7,1.3,and 2.7 g/kg groups.Six Wistar-Kyoto(WKY)rats served as a normal control group.All treatments were administered daily via intragastric administration for 14 consecutive days.After the final administration,behavioral assessments were conducted using the Morris water maze,open field test,and el-evated plus maze test.Dopamine(DA)and serotonin(5-HT)levels in the prefrontal cortex,striatum,and serum were measured by enzyme-linked immunosorbent assay(ELISA).Western blot and real-time PCR were employed to assess the protein and mRNA expression levels of key components in the AKT/GSK-3β/β-catenin signaling pathway in the pre-frontal cortex and striatum.Results:Compared with the normal control group,the model group exhibited a significant in-crease in the number of effective crossings(P<0.05)and reduced escape latency(P<0.01)in the Morris water maze,along with prolonged movement duration and distance in the open field test(P<0.01).The levels of DA and 5-HT in the prefrontal cortex,striatum,and serum significantly decreased(P<0.01).Protein expression levels of p-AKT/AKT,p-GSK-3β/GSK-3β,and β-catenin/β-actin in the prefrontal cortex and striatum were markedly downregulated(P<0.05 or P<0.01),the mRNA expression levels of Akt and β-catenin were significantly downregulated(P<0.05 or P<0.01),while the expression of Gsk3β mRNA was upregulated(P<0.05 or P<0.01).Compared with the model control group,the Jieyu Pills 2.7 g/kg group showed a significant increase in the number of effective crossings(P<0.01)and short-ened escape latency(P<0.05)in the Morris water maze,as well as reduced movement duration and distance in the open field test(P<0.01).The elevated plus maze test revealed significantly decreased percentages of time spent and entries into the closed arms(P<0.05 or P<0.01).DA and 5-HT levels in the prefrontal cortex,striatum,and serum were sig-nificantly elevated(P<0.05 or P<0.01).Protein expression levels of p-AKT/AKT,p-GSK-3β/GSK-3β,and β-cate-nin/β-actin were upregulated(P<0.05 or P<0.01),the mRNA expression levels of Akt and β-catenin were upregulated(P<0.05 or P<0.01),while Gsk3β mRNA expression was significantly downregulated(P<0.01).Conclusion:Jieyu Pills ameliorate cognitive deficits in a rat model of ADHD comorbid with anxiety model rats by modulating the expression of the AKT/GSK-3β/β-catenin signaling pathway in the prefrontal cortex and striatum.It enhances the expression of re-lated proteins and mRNAs in this signaling pathway,inhibits GSK-3β activity to reduce β-catenin degradation,and pre-vents endoplasmic reticulum stress.
王灿;苗明三;张硕;黄欣;康乐;井贺云;方晓艳;王霆;宋佳;李琳琳
河南中医药大学药学院,郑州 450046河南中医药大学药学院,郑州 450046||河南泰丰生物科技有限公司,郑州 450000河南中医药大学药学院,郑州 450046河南中医药大学药学院,郑州 450046河南中医药大学药学院,郑州 450046河南中医药大学药学院,郑州 450046河南中医药大学药学院,郑州 450046河南泰丰生物科技有限公司,郑州 450000河南泰丰生物科技有限公司,郑州 450000河南泰丰生物科技有限公司,郑州 450000
解郁丸注意缺陷多动障碍焦虑蛋白激酶/糖原合成酶激酶-3β/β-连环蛋白通路
Jieyu PillsAttention deficit hyperactivity disorder(ADHD)AnxietyAKT/GSK-3β/β-catenin pathway
《中药药理与临床》 2026 (6)
51-58,8
河南省重点研发专项(编号:241111311500)国家重点研发计划项目(编号:2022YFC3502101)河南省重点研发专项(编号:251111314100).
评论